A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+56.38%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$352M
AUM Growth
+$352M
Cap. Flow
+$108M
Cap. Flow %
30.66%
Top 10 Hldgs %
96.59%
Holding
17
New
4
Increased
1
Reduced
–
Closed
1

Top Buys

1
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
$50M
2
SIEN
Sientra, Inc.
SIEN
$36.9M
3
TARA icon
Protara Therapeutics
TARA
$20.3M
4
EVAR
Lombard Medical, Inc.
EVAR
$768K
5
ZLCS
ZALICUS INC COM NEW
ZLCS
$44K

Top Sells

1
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$56K

Sector Composition

1 Healthcare 47.2%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RNA
1
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$117M 33.09% 6,213,924 – –
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$50M 14.19% +1,301,413 New +$50M
SIEN
3
DELISTED
Sientra, Inc.
SIEN
$36.9M 10.47% +2,199,012 New +$36.9M
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$26.4M 7.49% 930,682 – –
SUPN icon
5
Supernus Pharmaceuticals
SUPN
$2.53B
$23.9M 6.8% 2,879,328 – –
EVAR
6
DELISTED
Lombard Medical, Inc.
EVAR
$22.1M 6.26% 3,473,452 +120,908 +4% +$768K
TARA icon
7
Protara Therapeutics
TARA
$120M
$20.3M 5.78% +2,017,872 New +$20.3M
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$19.4M 5.52% 1,182,196 – –
CEMP
9
DELISTED
Cempra, Inc.
CEMP
$16.8M 4.77% 714,285 – –
AMRN
10
Amarin Corp
AMRN
$311M
$7.85M 2.23% 8,087,486 – –
RGLS
11
DELISTED
Regulus Therapeutics
RGLS
$5.25M 1.49% 327,350 – –
ZGNX
12
DELISTED
Zogenix, Inc.
ZGNX
$3.18M 0.9% 2,335,218 – –
HPTX
13
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.5M 0.43% 62,500 – –
ACHV icon
14
Achieve Life Sciences
ACHV
$152M
$1.35M 0.38% 603,740 – –
ANTH
15
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$679K 0.19% 437,994 – –
ZLCS
16
DELISTED
ZALICUS INC COM NEW
ZLCS
$44K 0.01% +7,896 New +$44K
EPRS
17
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
– – -7,896 Closed -$56K